Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in Mendon, MA
NPI: 1336304526Primary Practice Location
UMASS MEMORIAL MEDICAL CENTER/UNIVERSITY CAMPUS
55 Lake Ave N, Worcester, MA
Primary Employer
Umass Memorial Medical Group, Inc.
triamcor.com
HQ Phone
Get M.D. David's Phone NumberMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 47 | 100 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 45 | 93 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 20 | 20 |
Authors: Brigitte Widemann, Akira Ishiyama, Ali Sepahdari, Joni Doherty, Derald Brackmann, Phioanh Nghiemphu, Naveed Wagle
Journal: J Neurooncol
Publication Date: 2024-02-19
Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.
Authors: Jacob Mandel, Mark Gilbert
Publication Date: 2014-07-04
Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.
Authors: Marta Penas-Prado, Anita Mahajan, Ian Mccutcheon, Steven Waguespack
Publication Date: 2016-04-24
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, PROCEDURE: Conventional Surgery, RADIATION: Fractionated Stereotactic Radiation Therapy, BIOLOGICAL: Atezolizumab, BIOLOGICAL: Tocilizumab
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, OTHER: Data Collection
Lead Sponsor: RTOG Foundation, Inc.
Collaborators: NovoCure Ltd.
Intervention / Treatment: DRUG: Bevacizumab, DEVICE: TTFields Therapy
